Histological improvement in chronic hepatitis B patients treated with bicyclol: real world experience

Histological improvement in chronic hepatitis B patients treated with bicyclol: real world experience

Abstract Background Bicyclol, the most commonly-used liver hepatoprotective drug in China, is often selected to control disease progression in CHB patients who refuse anti-viral treatment. However, data on histological changes after bicyclol treatment in these patients are scarce. Therefore, this st...

Full description

Bibliographic Details
Main Authors: Xiaoling Chi, Huanming Xiao, Meijie Shi, Gaoshu Cai, Yubao Xie, Junmin Jiang, Guangjun Tian, Shuduo Wu, Chaozhen Zhang, Pengtao Zhao, Jiezhen Chen
Format: Article
Language:English
Published: BMC 2019-06-01
Series:BMC Gastroenterology
Subjects:
Bicyclol
Chronic hepatitis B
Hepatoprotective drug
Liver biopsy
Online Access:http://link.springer.com/article/10.1186/s12876-019-1005-1

Internet

http://link.springer.com/article/10.1186/s12876-019-1005-1

Similar Items